SavedAdd your journal

Journals / Journal of Clinical and Analytical Medicine / 2014 / Cilt: 5 - Sayı: 2

Türk kadınlarında yaşam kalitesi ve depresyon ile mastaljinin etkileşimi

The interaction of mastalgia with depression and quality of life in Turkish women

Celalettin EROGLU
Kemal ARSLAN
Seher CİVCİK
Yavuz SELVI
Mehmet Ali ERYILMAZ
Pages
113–118
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion: Mastalgia negatively effected the life quality of women, psychological factors should be considered.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The interaction of mastalgia with the severity of depression and quality of life is examined.
📊
Key Findings & Data:Material and Method: This study was performed on 105 women screened for breast cancer having no organic pathology causing mastalgia.
💡
Conclusion & Impact:Discussion: Mastalgia negatively effected the life quality of women, psychological factors should be considered.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The interaction of mastalgia with the severity of depression and quality of life is examined. Material and Method: This study was performed on 105 women screened for breast cancer having no organic pathology causing mastalgia. The severity of pain, depression, and quality of life were evaluated through Visual Analogue Scale (VAS), Beck Depression Inventory (BDI), and Short Form-36 Health Survey (SF-36). Results: The mean VAS and BDI scores were 5 (1-10) and 17 (2-41), respectively. Of the patients, 49% (n=51) were referred to psychiatry polyclinics. Accordingly, 58% were depressive, 30% were anxious and 4% were depressive and anxious. The patients obtained the highest scores from physical and social functioning domains of SF-36. A moderate negative association was detected between age and physical function (PF) (r=-0.235, p=0.01), while there was a mild positive association between age and vitality energy (r=0.198, p=0.04). There was a mild negative association between BDI and PF (r=-0.146), while there were good positive associations between BDI and mental health and mental component summary scores (r=-0.563, r=-0.559). Moderate negative associations were detected between VAS and eight domains and 2 summary scores of SF-36. Discussion: Mastalgia negatively effected the life quality of women, psychological factors should be considered.

Özet

Amaç: Yaşam kalitesi ve depreyonun şiddeti ile mastaljinin etkileşimini değerlendirmeyi amaçladık. Gereç ve Yöntem: Bu çalışma, Ekim 2007 ile Haziran2008 tarihleri arasında Konya KETEM’ e başvuran, mastalji etyolojisi olabilecek organik bir patolojisi olmayan, meme kanseri taraması yapılan 105 kadın üzerinde yapıldı. Ağrının şiddeti, depresyon ve yaşam kalitesi sırasıyla Vizüe Analog Skala (VAS), Beck Depresyon Ölçeği (BDÖ) ve Short Form-36 (SF-36) testleriyle değerlendirildi. Bulgular: VAS ortalaması 5 (1-10), BDÖ ortalaması 17 (2-41) idi. Hastaların 51 (%49)’i Psikiyatri Kliniğine gönderildi. Bunagöre hastaların %58’ i depressif, %30’ u anksiyeteli ve %4’ ü hem depressif hem de anksiyeteli idi. Fiziksel ve sosyal uğraşıları olanlar SF-36 ölçeğinden en yüksek puanı aldı. Yaş ile fiziksel uğraşı arasında ılımlı bir negatif ilişki (r=-0.235, P=0.019 varken, yaş ile yaşam enerjisi arasında zayıf bir pozitifilişki (r=0.198, P=0.04) vardı. BDÖ ile fiziksel aktivite arasında zayıf bir negatif ilişki (r=-0.146) varken, BDÖ ile mental sağlık ve mental sağlık puanı arasında iyi bir pozitif ilişki (r=-0.563, r=-0.559) vardı. VAS ile SF-36’ nın arasında ılımlı bir negatif ilişki vardı. Tartışma: Mastalji, kadınların yaşam kalitesini negatif etkileyen psikolojik faktörler arasında göz önünde bulundurulmalıdır.

🔖

Cite This Article

EROGLU, C., ARSLAN, K., CİVCİK, S., SELVI, Y., ERYILMAZ, M. A. (2022). Türk kadınlarında yaşam kalitesi ve depresyon ile mastaljinin etkileşimi. Journal of Clinical and Analytical Medicine, Cilt: 5 - Sayı: 2, 113–118. https://ajindex.com/articles/561216

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Srivastavaa A, Mansela RE, Arvinda N, Prasadb K, Dharc A Chabraa. Evidence- based management of mastalgia: A meta-analysis of randomised trials. The Breast 2007;16(5):503–12
  2. Davies EL, Gateley CA, Miers M, Mansel RE. The long-term course of mastalgia. J R Soc Med 1998;91(9):462-4
  3. Carmichaela AR, Bashayana O, Nightingaleb P. Objective analyses of mastalgia in breast clinics: Is breast pain questionaire a useful tool in a busy breast clinic? The Breast 2006;15(4):498–502
  4. Millet AV, Dirbas FM. Clinical management of breast pain: a review. Obstet Gynecol Surv 2002;57(7):451-61
  5. Johnson KM, Bradley KA, Bush K, Gardella C, Dobie DJ, Laya MB. Frequency of mastalgia among women veterans. Association with psychiatric conditions and unexplained pain syndromes. J Gen Intern Med 2006;21 (Suppl 3):70-5
  6. Boyle CA, Berkowitz GS, Kelsey JL. Epidemiology of premenstrual symptoms. Am J Public Health 1987;77(3):349–50
  7. Leinster SJ, Whitehouse GH, Walsh PV. Cyclical mastalgia: clinical and mam- mographic observations in a screened population. Br J Surg 1987;74(3):220–2
  8. Deschamps M, Band PR, Coldman AJ. Clinical determinants of mammographic dysplasia patterns. Cancer Detect Prev 1996;20(6):610–9
  9. Ader DN, South-Paul J, Adera T, Deuster PA. Cyclical mastalgia: prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol 2001;22(2):71–6
  10. Gateley CA, Maddox PR, Pritchard GA, Sheridan W, Harrison BJ, Pye JK, et al. Plasma fatty acid profiles in benign breast disorders. Br J Surg 1992;79(5): 407-9
  11. Ecochard R, Marret H, Rabilloud M, Boehringer H, Mathieu C, Guerin JF. Gonadotropin level abnormalities in women with cyclic mastalgia. Eur J Obstet Gynecol Reprod Biol 2001;94(1):92-6
  12. Colegrave S, Holcombe C, Salmon P. Psychological characteristics of women presenting with breast pain. J Psychosom Res 2001;50(6):303-7
  13. Wong E, Cronin L, Griffi L, Irvine EJ, Guyatt GH. Problems of HROL assessment: How much is too much? J Clin Epidemiol 2001;54(11):1081-5
  14. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473-83
  15. Velanovich V. Experience with a generic quality of life instrument in a general surgical practice. Int J Surg Invest 2000;1(5):447-52
  16. Alonso J, Ferrer M, Gandek B, Ware JE Jr, Aaronson NK, Mosconi P, et al. Health- related quality of life associated with chronic conditions in eight countries: results from the